All Categories - SeekIn
8 août 2025 ·
Shenzhen, China - August 7, 2025 - SeekIn Inc., a leading innovator in liquid biopsy-based cancer...
27 juillet 2025 ·
San Diego, July 28, 2025 - SeekIn Inc., a leader in blood-based early cancer detection and...
3 juillet 2025 ·
San Diego, July 2, 2025 -- A new prospective study published in BMC Cancer demonstrates that a...
18 juin 2025 ·
San Diego, June 18, 2025 -- Biotecgen (Colombia) and OncoInv (The Netherlands) have joined forces...
2 juin 2025 ·
San Diego, May 26, 2025 -- A groundbreaking study published in the Journal of Molecular...
CHICAGO, United States, May 30, 2025 - SeekIn Inc., a leader in blood-based cancer early...
Brussels, Belgian - May 18-22, 2025 SeekIn Inc., a leader in blood-based cancer early detection...
Amsterdam, the Netherlands - May 14-15, 2025 SeekIn Inc., a leader in blood-based cancer early...
8 avril 2025 ·
Longevity Medical Institute™ (LMI), Mexico's premier center for regenerative medicine, anti-aging...
BIOS (Pakistan) and OncoInv (The Netherlands) have joined forces to make multi-cancer early...
24 janvier 2025 ·
San Diego, January 22, 2025 — SeekIn Inc, a leader in blood-based cancer early detection and...
SAN DIEGO, United States, January 22, 2025 -- SeekIn Inc, aleader in blood-based cancer early...
30 décembre 2024
SAN DIEGO, United States, December 30, 2024 -- SeekIn Inc, a leader in blood-based cancer early...
San Diego, California, USA - November 13-16, 2024 SeekIn Inc., a leader in blood-based cancer...
17 décembre 2024
Amsterdam, The Netherlands - October 26, 2024 Dr. Mao Mao, CEO of SeekIn and a globally...
Chicago, October 15-16, 2024 — At the Precision Oncology & Diagnostics, Bernadette Toner, CEO of...
SeekIn announced a innovative two-step multi-cancer screening strategy at the Early Detection of...
15 octobre 2024
OncoInv and Healthcare Systems Mexico have joined forces to make multi cancer early detection...
17 août 2024 ·
SeekIn Inc., a leader in blood-based cancer early detection and monitoring technology, announced...
Excellion (Nigeria) and OncoInv (The Netherlands) have joined forces to make multi cancer early...